Brachytherapy boost improves survival and decreases risk of developing distant metastases compared to external beam radiotherapy alone in intermediate and high risk group prostate cancer patients.
Miszczyk M, Magrowski Ł, Krzysztofiak T, Stando R, Majewski W, Stawiski K, Masri O, Ciepał J, Depowska G, Chimiak K, Bylica G, Czapla B, Masri M, Cichur F, Jabłońska I, Gmerek M, Nowicka Z, Wojcieszek P, Sadowski J, Suwiński R, Rajwa P, Goldner G, Moll M.
Miszczyk M, et al. Among authors: jablonska i.
Radiother Oncol. 2023 Jun;183:109632. doi: 10.1016/j.radonc.2023.109632. Epub 2023 Mar 23.
Radiother Oncol. 2023.
PMID: 36963442
Free article.